CLINICAL_TRIALS
trial_result
· 2015-04-07
Clinical Trial Update: Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study [Phase 3]
Summary
Phase 3 randomized trial evaluating switching from hydroxyurea to ruxolitinib for relief of polycythemia vera symptoms; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Polycythemia Vera | Phase 3 | Status: COMPLETED | Results posted: 2015-04-07